SCHEMBL6488337

SCHEMBL6488337

CC(=O)Nc1cccc2[nH]c(-c3cc[nH]n3)cc12

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PARP14 Q460N5 4/20 0.44
KMT2A Q03164 3/20 0.40
MEN1 O00255 2/20 0.40
KDM4E B2RXH2 4/20 0.39
MTNR1A P48039 1/20 0.39
MTNR1B P49286 1/20 0.39
ITK Q08881 1/20 0.38
POLB P06746 1/20 0.38
IDO1 P14902 1/20 0.38
TDO2 P48775 1/20 0.38
ALDH1A1 P00352 1/20 0.37
HPGD P15428 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
MAOA P21397 1/20 0.37
CASP6 P55212 1/20 0.37
FYN P06241 1/20 0.36
ERCC1 P07992 1/20 0.36
FEN1 P39748 1/20 0.36
ERCC4 Q92889 1/20 0.36
PIK3CA P42336 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5756356 0.84 KDM4E (0.44) PARP14KMT2AMEN1KDM4EMTNR1B
SCHEMBL5757017 0.78 HDAC11 (0.43) KDM4EMTNR1AITKALDH1A1HPGD
SCHEMBL5755265 0.76 PBRM1 (0.40) KMT2AMEN1KDM4EITKPOLB
SCHEMBL5752672 0.76 HDAC11 (0.41) KMT2AMEN1KDM4EALDH1A1HPGD
SCHEMBL6488203 0.76 DAO (0.46) KMT2AMEN1KDM4EITKALDH1A1
SCHEMBL6479227 0.76 HRH4 (0.38) KDM4EITKIDO1ALDH1A1
SCHEMBL5752743 0.75 PARP1 (0.40) KDM4EALDH1A1
SCHEMBL5754686 0.75 KDR (0.43) KDM4EMTNR1AMTNR1BITK
SCHEMBL5755838 0.75 BRAF (0.44) KMT2AMEN1KDM4EALDH1A1SMN1; SMN2
SCHEMBL6490316 0.74 NHERF1 (0.47) KMT2AMEN1KDM4EALDH1A1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050032869-A1 Pyrazolyl-indole derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them PHARMACIA ITALIA S.P.A. (IT) 2005-02-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050032869-A1 Pyrazolyl-indole derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them MAP3K9, MAP3K20, MAP3K19 PARP14 973/4885KMT2A 1158/4885MEN1 2784/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.